Advertisement
Screener

SELLAS Life Sciences Group, Inc. (SLS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SELLAS Life Sciences Group, Inc. Cash Flow Breakdown

Cash flow breakdown shows where SELLAS Life Sciences Group, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $28.39M went out.
  • Fiscal year ended 2025-12-31: from financing, $86.30M came in.
  • Fiscal year ended 2025-12-31: change in cash, $57.91M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$28.39M-$527.00K$112.00K$86.71M*$57.91M
2024-12-31-$35.40M$0.00-$64.00K$98.00K$46.72M*$11.36M
2023-12-31-$31.41M-$5.50M-$31.00K$289.00K$22.06M*-$14.60M
2022-12-31-$23.81M-$4.50M$0.00$1.05M$23.03M*-$4.23M
2021-12-31-$26.02M$0.00$9.01M$3.07M*-$13.95M
2020-12-31-$10.42M$29.60M$8.84M*$28.02M
2019-12-31-$17.64M$0.00$0.00$15.97M$3.60M*$1.93M
2018-12-31-$30.42M$0.00-$487.00K-$7.60M$21.56M$9.65M*-$7.30M
2017-12-31-$10.99M$12.16M$0.00-$473.00K$6.01M$6.70M
2016-12-31-$11.85M-$85.00K-$5.58M$1.50M$33.53M-$12.96M*$4.57M
2015-12-31-$48.16M$10.39M-$3.91M$0.00$47.42M$6.08M
2014-12-31-$42.87M-$5.53M-$1.77M$0.00$10.70M$15.32M*-$24.14M
2013-12-31-$28.93M-$12.04M$9.87M$37.54M$8.54M*$14.98M
2012-12-31-$20.97M-$87.00K$360.00K*$0.00$36.38M$5.70M*$21.37M
2011-12-31-$14.67M$14.00K$0.00$18.61M$581.00K*$4.54M
2010-12-31-$10.26M-$106.00K-$3.85M$15.23M$1.21M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$7.59M*$0.00*$38.83M*
2026-03-31-$8.85M$66.00K$44.08M*$35.30M
2025-12-31-$4.92M*$0.00*$32.39M*
2025-09-30-$7.07M*$64.00K*$26.03M*
2025-06-30-$7.33M*$0.00*$4.23M*
2025-03-31-$9.07M$48.00K$23.53M*$14.51M
2024-12-31-$7.15M*$0.00*$0.00*
2024-09-30-$7.81M*$0.00*$47.00K*$19.64M*
2024-06-30-$9.68M*$0.00*
2024-03-31-$10.76M$51.00K$26.59M*$15.88M
2023-12-31-$4.83M*$0.00*$21.00K*$3.37M*
2023-09-30-$6.89M*-$3.00M*$0.00*
2023-06-30-$7.57M*$0.00*
2023-03-31-$12.13M$268.00K$18.64M*$6.78M
2022-12-31-$5.15M*$0.00*$929.00K*
2022-09-30-$5.75M*$0.00*$69.00K*
2022-06-30-$5.76M*$50.00K*$22.95M*
2022-03-31-$7.15M$0.00-$7.10M
2021-12-31-$4.98M*$0.00*$0.00*
2021-09-30-$5.88M*$0.00*$2.24M*
2021-06-30-$4.90M*$0.00*$6.78M*
2021-03-31-$10.27M$0.00$3.00M*-$7.27M
2020-12-31$3.42M*$15.14M*$8.53M*
2020-09-30-$3.63M*$8.49M*
2020-06-30-$3.38M*-$25.00K*
2020-03-31-$6.83M$5.99M-$531.00K
2019-12-31-$4.18M*$0.00*$0.00*$2.32M*
2019-09-30-$3.82M*$0.00*$0.00*-$129.00K*
2019-06-30-$4.66M*$0.00*$13.78M*$1.05M*
2019-03-31-$4.99M$0.00$0.00$2.23M*-$2.76M
2018-12-31-$4.55M*$0.00*-$76.00K*$0.00*
2018-09-30-$14.16M*-$376.00K*-$6.94M*$21.56M*
2018-06-30-$6.30M*$0.00*$4.21M*
2018-03-31-$5.40M-$589.00K$5.33M*-$664.00K
2017-12-31-$1.74M*$12.16M*$0.00*-$120.00K*$0.00*$1.53M*
2017-09-30-$2.40M*$25.00K*$0.00*-$1.00K*$0.00*$0.00*-$5.16M*
2017-06-30-$3.05M*-$7.00K*-$352.00K*-$4.45M*-$9.52M*$19.97M*-$9.57M*
2017-03-31-$3.80M-$18.00K$0.00-$3.80M
2016-12-31$25.07M*$971.00K*-$800.00K*-$22.14M*$1.73M*$4.96M*$9.78M*
2016-09-30-$12.21M*$0.00*$0.00*$0.00*$11.62M*$5.52M*$4.92M*
2016-06-30-$11.49M*$0.00*-$3.75M*$23.64M*$0.00*-$15.12M*
2016-03-31-$13.22M-$1.06M-$1.03M$0.00$20.19M$4.98M
2015-12-31-$15.28M*$11.21M*-$1.01M*$0.00*$0.00*-$5.08M*
2015-09-30-$9.46M*-$248.00K*-$988.00K*$0.00*$0.00*-$10.47M*
2015-06-30-$11.86M*-$50.00K*-$967.00K*$5.29M*-$7.58M*
2015-03-31-$11.56M-$518.00K-$947.00K$42.12M$29.21M
2014-12-31-$10.73M*-$109.00K*-$858.00K*$0.00*$10.70M*-$997.00K*
2014-09-30-$11.12M*-$3.08M*-$901.00K*$0.00*$0.00*-$14.52M*
2014-06-30-$12.97M*-$312.00K*-$4.00K*$0.00*-$13.27M*
2014-03-31-$8.05M-$2.03M-$3.00K$0.00$14.72M*$4.64M
2013-12-31-$8.49M*-$2.80M*$0.00*$19.00K*$7.67M*-$3.61M*
2013-09-30-$7.98M*$720.00K*$0.00*$37.74M*$30.48M*
2013-06-30-$7.12M*$131.00K*$0.00*-$360.00K*$10.79M*$3.44M*
2013-03-31-$5.33M-$10.09M$0.00*$0.00*-$15.33M
2012-12-31-$5.18M*$0.00*$360.00K*$0.00*$22.44M*$17.38M*
2012-09-30-$4.17M*$0.00*$0.00*$0.00*$72.00K*-$3.81M*
2012-06-30-$6.75M*-$87.00K*$0.00*$13.48M*$3.88M*$10.53M*
2012-03-31-$4.88M$0.00*$0.00*$385.00K$1.77M*-$2.73M
2011-12-31-$4.17M*-$101.00K*$0.00*$6.00K*-$4.26M*
2011-09-30-$3.41M*$0.00*$0.00*$549.00K*$624.00K*-$2.24M*
2011-06-30-$4.06M*$155.00K*$10.75M*$6.82M*
2011-03-31-$3.03M-$40.00K$7.31M$4.22M
2010-12-31-$1.87M*$5.95M*$0.00*$0.00*$4.05M*
2010-09-30-$2.24M*-$5.00K*$0.00*$0.00*-$2.26M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34